Zepbound soars in first quarter on market as Eli Lilly rides GLP-1 wave
Zepbound, which recently received approval for treating obesity from the FDA, notched nearly $176 million in its first quarter on the market.
Source: mmm-online.com
Fauna Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fauna Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fauna Bio Today - Breaking & Trending Today
Don't Be Fooled by These 3 Misleading Facts About Eli Lilly Stock
Don't let a few disparate facts dominate your view of this company.
Source: yahoo.com
Fauna Bio Researcher Awarded NASA Early-Stage Grant to Study Hibernation in Space
EMERYVILLE, Calif.--(BUSINESS WIRE)--Jan 22, 2024--
Source: bdtonline.com
Here's What Investors Should Expect From Eli Lilly Stock in 2024
More headlines on the horizon.
Source: fool.com
Here's What Investors Should Expect From Eli Lilly Stock in 2024
More headlines on the horizon.
Source: yahoo.com